Literature DB >> 15918578

Novel lead structures for antimalarial farnesyltransferase inhibitors.

K Kettler1, J Sakowski, J Wiesner, R Ortmann, H Jomaa, M Schlitzer.   

Abstract

Through the combination of nitrophenylfurylacryloyl moiety which has been designed to occupy an aryl binding site of farnesyltransferase with several AA(X)-peptidomimetic substructures some novel farnesyltransferase inhibitors were obtained. Evaluation of their antimalarial activity and some initial modifications yielded a 4-benzophenone- and a sulfonamid-based novel lead for antimalarial farnesyltransferase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918578     DOI: 10.1002/chin.200536090

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  1 in total

1.  Design, practical synthesis, and biological evaluation of novel 6-(pyrazolylmethyl)-4-quinoline-3-carboxylic acid derivatives as HIV-1 integrase inhibitors.

Authors:  Liming Hu; Song Yan; Zaigang Luo; Xiao Han; Yujie Wang; Zhanyang Wang; Chengchu Zeng
Journal:  Molecules       Date:  2012-09-06       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.